HOME >> MEDICINE >> NEWS
Cell marker identifies patients who are more likely to respond to taxol

Researchers at The University of Texas M. D. Anderson Cancer Center have found a potential predictor of response to the chemotherapy drug Taxol, which is commonly used before or after surgery for stage I-III breast cancers, even though only a subset of women ultimately benefit from this treatment.

Patients whose breast cancer cells have lost their ability to express a protein called "tau" are twice as likely to have a good response to Taxol treatment, the researchers report at the annual San Antonio Breast Cancer Symposium meeting.

The finding makes sense because tau promotes the assembly of microtubules, which provide structure to the cell and help it divide. Taxol works by binding to microtubules to form an inappropriately stable structure which ultimately leads to cell death. "In the absence of tau, Taxol stabilizes microtubules more easily," says the study's lead researcher, Lajos Pusztai, M.D., Ph.D., an associate professor in the Department of Breast Medical Oncology.

If validated in larger studies, the finding suggests that tumor tissue could be screened to predict if it will respond to Taxol, says Pusztai. "If it doesn't, perhaps other chemotherapy regimens would work better."

The results also suggest a way to improve the use of Taxol, Pusztai says. "If you block the effect of tau with an agent, you could possibly increase the effectiveness of Taxol in more patients, making them super responders."

The researchers came up with their discovery after examining breast cancer biopsy samples taken from 82 patients, 21 of whom had a complete disappearance of their cancer after Taxol-containing treatment. They looked at the difference between these responders and non-responders in 22,000 genes, and found that tumors were highly sensitive to treatment that had low levels of tau messenger RNA (mRNA) expression in their cancer cells. This observation was confirmed by examining tau protein expression using a routine pathologi
'"/>

Contact: Nancy Jensen
nwjensen@mdanderson.org
713-792-0655
University of Texas M. D. Anderson Cancer Center
8-Dec-2004


Page: 1 2

Related medicine news :

1. New marker for early diagnosis of kidney failure identified
2. A marker for new blood vessel formation in tumors
3. Biochemical marker aids prognosis in liver transplant patients
4. A biomarker to predict osteoarthritis
5. Mayo Clinic discovers potential marker for aggressive kidney cancer
6. Pitt researchers identify biomarkers of lupus which could lead to quicker and better diagnosis
7. Inflammatory marker may be early sign of blood vessel blockages
8. Protein marker predicts possible heart damage after chemotherapy
9. University of Pittsburgh researchers identify potential biomarker for renal cell carcinoma
10. Prostate cancer marker could lead to earlier diagnosis say Univ. of Pittsburgh researchers
11. First biomarkers to diagnose Lou Gehrigs disease found in CNS

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:12/8/2019)... (PRWEB) , ... December 08, 2019 , ... ... education planning, has announced the Top 26 Logistics Degree Programs for 2020. The ... universities in the nation. Each program is evaluated based on curriculum quality, graduation ...
(Date:12/6/2019)... JOSE, Calif. (PRWEB) , ... December 06, 2019 ... ... into the era of assembling and manufacturing implantable medical devices, which is a ... , As the name suggests, implantable medical devices are surgically inserted into various ...
(Date:12/6/2019)... ... ... Allegheny Health Network (AHN) has named Kymberly Gyure, MD, Chair of the AHN Pathology ... previously served as AHN’s Vice Chair of Pathology and Laboratory Medicine, and Director of ... of the pathology faculty at Drexel University College of Medicine. , Dr. Gyure ...
(Date:12/6/2019)... ... , ... Brain Sentinel, Inc. announces it is hosting a ... Meeting. The symposium, “Fundamentals of Quantitative Surface Electromyography (sEMG) for Long-Term Monitoring”, has ... ictal events;, 2. Review specific sEMG patterns of motor seizures and the quantitative ...
(Date:12/5/2019)... Mo. (PRWEB) , ... December 05, 2019 , ... ... is offering new, high resolution ultrasound (HRUS) technology to help their patients more ... in Chesterfield, MO, is participating in this study and reporting on his experience. ...
Breaking Medicine News(10 mins):
(Date:11/30/2019)... ... November 28, 2019 , ... Craig ... was elected chairman of the board of trustees of the International Safety ... Votel, President & CEO, Ergodyne , was elected vice chairman. , Nate ...
(Date:11/30/2019)... ... November 29, 2019 , ... ACC Medlink has been waiting more ... due to Amazon’s incredibly large purchase of these vehicles for their Prime ... they’ve recently received word on vehicle availability and are expecting to have the new ...
(Date:11/30/2019)... , ... November 30, 2019 , ... ... best residential trauma and PTSD treatment programs in British Columbia, Canada, is pleased ... a body-based talk therapy, integrating current findings from neuroscience to transform traumatic memories ...
Breaking Medicine Technology:
Cached News: